Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sanifit Therapeutics S.A.

http://www.sanifit.com

Latest From Sanifit Therapeutics S.A.

Spain’s SpliceBio Defies Sentiment With €50m Financing

The Barcelona-based firm, which has a protein splicing platform that aims to address the major limitation of delivering large genes using AAV vectors, has sealed the largest series A fundraising by a Spanish biotech.

Spain Financing

CSL Makes $11.7bn Move On Vifor Pharma In Renal Disease Push

Confirming rumors of an acquisition, CSL will venture into some new territories as well as boost its renal franchise when it takes over Switzerland’s Vifor Pharma in a deal worth $11.7bn.

Companies Deals

The Biotech Rollercoaster Ride: From Lab To Buyout

After investing more than €23m in Sanifit, the Spanish firm being acquired by Vifor Pharma, Caixa Capital's director of life sciences investments spoke to Scrip about the venture capital firm's long-term approach.

Spain Financing

Vifor Bulks Up Renal Franchise With Sanifit And Inositec Acquisitions

A couple of months after licensing the late-stage kidney disease drug sparsentan from Travere, the Swiss group has beefed up its nephrology activities by buying Mallorca-based Sanifit and Swiss outfit Inositec.

M & A Renal
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • CSL Vifor
    • Sanifit Laboratories
    • Laboratoris Sanifit S.L.
UsernamePublicRestriction

Register